US Stock MarketDetailed Quotes
MDWD MediWound
- 17.650
- +0.330+1.91%
Close May 13 16:00 ET
- 17.650
- 0.0000.00%
Post 16:00 ET
167.53MMarket Cap-23533P/E (TTM)
17.970High17.530Low30.25KVolume17.700Open17.320Pre Close534.95KTurnover0.58%Turnover RatioLossP/E (Static)9.49MShares19.86052wk High5.30P/B92.70MFloat Cap7.10052wk Low--Dividend TTM5.25MShs Float135.170Historical High--Div YieldTTM2.54%Amplitude7.100Historical Low17.687Avg Price1Lot Size
About MediWound Company
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
Company Profile
SymbolMDWD
Company NameMediWound
Listing DateMar 20, 2014
Issue Price14.00
Founded2000
CEOMr. Ofer Gonen
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address42 Hayarkon Street
CityYavne
ProvinceHaMerkaz
CountryIsrael
Zip Code8122745
Phone972-77-971-4100
Websitehttp://www.mediwound.com
Company Executives
- Name
- Position
- Salary
- Ofer Gonen
- Director and Chief Executive Officer
- 1.13M
- Shmulik Hess
- Chief Operating Officer and Chief Commercial Officer
- --
- Ety Klinger
- Chief Research and Development Officer
- 479.00K
- Hani Luxenburg
- Chief Financial Officer
- 244.00K
- Dr. Robert Snyder, M. Sc.
- Chief Medical Officer
- --
- Yaron Meyer
- Executive Vice President, General Counsel and Corporate Secretary
- 379.00K
- Nachum Shamir
- Chairman of the Board
- --
- Stefan T. Wills
- Director
- --
- Shmuel Rubinstein
- Independent Director
- --
- Dr. Vickie R. Driver
- Independent Director
- --
- David Fox
- Independent Director
- --
- Stephen T. Willis
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg